EMCIP
ZYME icon

Ewing Morris & Co Investment Partners’s Zymeworks ZYME Stock Holding History

Ewing Morris & Co Investment Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Hold
10,850
– – 0.12% 78
2025
Q4 		$289K Hold
10,850
– – 0.13% 85
2025
Q3 		$185K Buy
+10,850
New +$155K 0.08% 92

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ewing Morris & Co Investment Partners's ZYME Position: Q1 2026 in Review

Ewing Morris & Co Investment Partners held its Zymeworks (ZYME) position steady in Q1 2026 at 10,850 shares worth $272K. The position accounts for 0.12% of the portfolio, ranked #78.

Ewing Morris & Co Investment Partners first reported a position in ZYME in Q3 2025 and has held it in 3 quarters since. The position peaked at $289K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Ewing Morris & Co Investment Partners held 10,850 shares of Zymeworks worth $272K as of Q1 2026.
  • Ewing Morris & Co Investment Partners left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up 0.12% of Ewing Morris & Co Investment Partners's portfolio in Q1 2026, its #78 holding.
  • Ewing Morris & Co Investment Partners first reported a position in Zymeworks in Q3 2025 and has held it in 3 quarters since.
  • Ewing Morris & Co Investment Partners's Zymeworks position peaked at $289K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Ewing Morris & Co Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.